BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9848724)

  • 21. Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells.
    Van Sande J; Costa MJ; Massart C; Swillens S; Costagliola S; Orgiazzi J; Dumont JE
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5366-74. PubMed ID: 14602775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional significance of the second extracellular loop of thyrotropin receptor in thyrotropin- and thyroid stimulating antibody-dependent signal transduction.
    Kaneshige M; Haraguchi K; Endo T; Anzai E; Onaya T
    Horm Metab Res; 1995 Jun; 27(6):267-71. PubMed ID: 7557836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor.
    Hidaka Y; Guimaraes V; Soliman M; Yanagawa T; Okamoto Y; Quintans J; DeGroot LJ
    Endocrinology; 1995 Apr; 136(4):1642-7. PubMed ID: 7534706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma inhibition of human thyrotropin receptor gene expression.
    Nishikawa T; Yamashita S; Namba H; Usa T; Tominaga T; Kimura H; Izumi M; Nagataki S
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1084-9. PubMed ID: 8408457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the thyrotropin (TSH) receptor by human chorionic gonadotropin and luteinizing hormone in Chinese hamster ovary cells expressing functional human TSH receptors.
    Yoshimura M; Hershman JM; Pang XP; Berg L; Pekary AE
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1009-13. PubMed ID: 7691861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical
    Kahaly GJ; Steiner L; van der Lee MMC; van Achterberg TAE; Arends RJ; Karstens WFJ; Weirauch T; Henseling J; Frommer L; Wolf J; George A
    Thyroid; 2023 Jun; 33(6):732-742. PubMed ID: 37016815
    [No Abstract]   [Full Text] [Related]  

  • 28. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
    Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
    Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
    Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
    J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

  • 32. Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line.
    Namba H; Yamashita S; Usa T; Kimura H; Yokoyama N; Izumi M; Nagataki S
    Endocrinology; 1993 Feb; 132(2):839-45. PubMed ID: 8381075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies.
    Ludgate M; Perret J; Parmentier M; Gerard C; Libert F; Dumont JE; Vassart G
    Mol Cell Endocrinol; 1990 Oct; 73(1):R13-8. PubMed ID: 1981364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous responses of recombinant human thyrotropin receptor to immunoglobulins from patients with Graves' disease.
    Endo T; Ohmori M; Ikeda M; Anzai E; Onaya T
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1391-6. PubMed ID: 1354957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
    Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
    Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding.
    Haraguchi K; Saito T; Endo T; Onaya T
    Life Sci; 1994; 55(12):961-8. PubMed ID: 7914657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both the 5' and 3' noncoding regions of the thyrotropin receptor messenger ribonucleic acid influence the level of receptor protein expression in transfected mamalian cells.
    Kakinuma A; Chazenbalk G; Filetti S; McLachlan SM; Rapoport B
    Endocrinology; 1996 Jul; 137(7):2664-9. PubMed ID: 8770884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.